EULAR issue new guidelines for the management of RA10 March 2020The information gathered for these updates came through a systematic review of studies focused on the safety and effectiveness of disease modifying anti-rheumatic drugs (DMARDs), when taken alone or in combination and included standard and biologic DMARDs. The task force agreed on 5 overarching principles and 12 recommendations by devising related questions, eliciting expert opinions, and reaching consensus by vote. These recommendations are summarised here (link to: https://www.rheumatologyadvisor.com/home/topics/rheumatoid-arthritis/updated-eular-recommendations-for-rheumatoid-arthritis-management-with-dmards/) To read the guidelines in full, click here (link to: https://ard.bmj.com/content/early/2020/01/22/annrheumdis-2019-216655)